105 related articles for article (PubMed ID: 3702866)
1. [Conformational aspects of beta-trypsin interactions with substrates and pancreatic trypsin inhibitor. II. Structure of tetrahedral adducts and acylenzyme].
Aliev RE; Godzhaev NM; Popov EM
Mol Biol (Mosk); 1986; 20(2):346-56. PubMed ID: 3702866
[TBL] [Abstract][Full Text] [Related]
2. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. I. Conformational properties of residues in the enzyme-active center and the structure of a non-valent enzyme-substrate complex].
Godzhaev NM; Aliev RE; Popov EM
Mol Biol (Mosk); 1986; 20(1):102-19. PubMed ID: 3951435
[TBL] [Abstract][Full Text] [Related]
3. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
Popov EM; Godzhaev NM; Aliev RE
Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
[TBL] [Abstract][Full Text] [Related]
4. [Determination and comparative analysis of the conformation of bovine pancreatic trypsin inhibitor and trypsin inhibitors E and K from the data of two-dimensional 1H-NMR spectroscopy].
Sherman SA; Andrianov AM
Mol Biol (Mosk); 1985; 19(5):1301-9. PubMed ID: 4079926
[TBL] [Abstract][Full Text] [Related]
5. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
7. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
[TBL] [Abstract][Full Text] [Related]
8. The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI.
Helland R; Otlewski J; Sundheim O; Dadlez M; Smalås AO
J Mol Biol; 1999 Apr; 287(5):923-42. PubMed ID: 10222201
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of hierarchical multiple substates of a protein. III: Side chain and main chain local conformations.
Noguti T; Go N
Proteins; 1989; 5(2):113-24. PubMed ID: 2748575
[TBL] [Abstract][Full Text] [Related]
10. [Study of trypsin-substrate and trypsin-inhibitor complexes. 1. Conformation of Asp-102, His-57 and Ser-195 residues in the trypsin active center].
Godzhaev NM
Mol Biol (Mosk); 1984; 18(5):1432-5. PubMed ID: 6438492
[TBL] [Abstract][Full Text] [Related]
11. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
12. Beta-secondary and solvent deuterium kinetic isotope effects on catalysis by the Streptomyces R61 DD-peptidase: comparisons with a structurally similar class C beta-lactamase.
Adediran SA; Pratt RF
Biochemistry; 1999 Feb; 38(5):1469-77. PubMed ID: 9931012
[TBL] [Abstract][Full Text] [Related]
13. Studies on trypsin inhibitors. Part V. Synthesis of the protected octapeptide (sequence 36-43) of porcine pancreatic secretory trypsin inhibitor II (Kazal).
Tomatis R; Guggi A; Menegatti E; Rocchi R
Int J Pept Protein Res; 1976; 8(2):107-13. PubMed ID: 1270185
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and dynamics of PEC-60, a protein of the Kazal type inhibitor family, determined by nuclear magnetic resonance spectroscopy.
Liepinsh E; Berndt KD; Sillard R; Mutt V; Otting G
J Mol Biol; 1994 May; 239(1):137-53. PubMed ID: 8196042
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
[TBL] [Abstract][Full Text] [Related]
16. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
17. [Theoretical conformational analysis of noinvalent carboxypeptidase A complexes with inhibitors and substrates].
Lipkind GM; Paslen VV
Mol Biol (Mosk); 1980; 14(5):1142-50. PubMed ID: 7421820
[TBL] [Abstract][Full Text] [Related]
18. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
Chen CC; Rahil J; Pratt RF; Herzberg O
J Mol Biol; 1993 Nov; 234(1):165-78. PubMed ID: 8230196
[TBL] [Abstract][Full Text] [Related]
19. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
Liu Y; Breslauer K; Anderson S
Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
[TBL] [Abstract][Full Text] [Related]
20. Native-like conformations are sampled by partially folded and disordered variants of bovine pancreatic trypsin inhibitor.
Tulla-Puche J; Getun IV; Woodward C; Barany G
Biochemistry; 2004 Feb; 43(6):1591-8. PubMed ID: 14769035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
